Program: Education Program
Session: Goldilocks and Transplant Timing in Inherited Marrow Failure Syndromes: Too Early, Too Late, Just Right?
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, Translational Research, Bone Marrow Failure Syndromes, Inherited Marrow Failure Syndromes, Clinical Research, Genetic Disorders, Diseases, Therapies, Transplantation
Session: Goldilocks and Transplant Timing in Inherited Marrow Failure Syndromes: Too Early, Too Late, Just Right?
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, Translational Research, Bone Marrow Failure Syndromes, Inherited Marrow Failure Syndromes, Clinical Research, Genetic Disorders, Diseases, Therapies, Transplantation
Sunday, December 10, 2023, 9:30 AM-10:45 AM
Disclosures: Agarwal: Rejuveron: Divested equity in a private or publicly-traded company in the past 24 months, Membership on an entity's Board of Directors or advisory committees, Research Funding; Cimeio Therapeutics: Current holder of stock options in a privately-held company, Membership on an entity's Board of Directors or advisory committees; Astellas: Research Funding.
OffLabel Disclosure: